2025-11-21
1 2 3 4 5 6
Note
We will not make definitive decisions here and now:
Proposed structure and content will be defined by consensus after the WHO team have reviewed and addressed all comments.
We won’t discuss fine-grained decisions on variable coding or the structure of the data:
This is constrained by the WHO Global Clinical Platform.
We will not vote on specific variables:
The WHO team will use these discussions to support the trade-offs required to reach the lightweight end-product.
After the first meeting:
The WHO technical team will compile a new version of the Case Report Form (CRF) based on the discussions
We may ask you to complete prioritisation surveys if there are difficult specific decisions
We will reconvene in a second meeting to iterate this discussion
Another meeting may be required to finalise and ensure consensus (not yet planned).
To support a harmonised, lightweight, and near real-time clinical surveillance system for dengue that enables facilities and national programmes to monitor clinical outcomes and support care quality improvement.
Note
Represent a marker which is related to quality of care and is modifiable by an intervention:
Feasibility of capture:
- Available within 7 days to clinical staff.
Objectivity:
- Standardised definition and method of ascertainment.
Close to universally relevant:
- All settings.
Non-rare:
- Not designed for never events for example.
Discriminatory:
A priori:
Additional based on survey:
Demographics
Symptoms
Laboratory and Imagery:
Diagnosis:
Treatments:
1 2 3
Important
Variables below are considered Core of the WHO Clinical data platform and are not to be discussed as part of this process.
1 2 3
Important
Variables below are considered Core of the WHO Clinical data platform and are not to be discussed as part of this process.
1 2 3
Important
Variables below are considered Core of the WHO Clinical data platform and are not to be discussed as part of this process.
1 2 3
Important
Variables below are considered Core of the WHO Clinical data platform and are not to be discussed as part of this process.
1 2 3
Dengue - Light CRF 2025